All lobbying filings

Bracewell LLP

Bracewell LLP filed a Q4 report for Aquestive Therapeutics on January 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Aquestive Therapeutics · pharmaceutical company

As filed: BRACEWELL LLP for AQUESTIVE THERAPEUTICS.

All filings by Bracewell LLP · Everything Aquestive Therapeutics has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Indiana

Official filing document

Lobbyists on this filing 1

EDWARD KRENIK

Previously held: Assoc. Admin. Cong. Affairs, EPA (2001-03); Leg.Director,Rep. Frelinghuysen (1994-01); Leg. Asst/Assoc.Staff, Rep.Dean Gallo (1989-94); Leg. Asst. Sen. Durenberger(1987-89)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Consumer Issues/Safety/Products

CPSC issues related to packaging

Health Issues

Give Kids a Chance Act (H.R.1262),(S.932)

Bills named in this filing 2

H.R. 1262
Mikaela Naylon Give Kids a Chance Act
S. 932
Give Kids a Chance Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.